Key Insights

Highlights

Treatment Research

1 treatments under study, led by Food Supplement Colipral In Filmcoated Tablets Containing Escherichia Coli 5c Lmg S33222

Research Leaders

9 sponsors active, led by University of Louisville

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Not Yet Recruiting1
Recruiting1

Clinical Trials (2)

Research Network

Common Treatments

  • Food Supplement Colipral In Filmcoated Tablets Containing Escherichia Coli 5c Lmg S332221

Active Sponsors

  • University of Louisville1
  • Wake Forest University1
  • Texas Tech University Health Sciences Center, El Paso1
  • University of Padova1
  • Johns Hopkins Bloomberg School of Public Health1

Top Investigators

Related Conditions

  • Gastroparesis Due To Diabetes Mellitus Type Ii1
  • Gastroparesis1
  • Gastroparesis Due To Diabetes Mellitus Type I1
  • Gastroparesis Nondiabetic1
  • Gastrointestinal Disorder1

Activity Timeline